Evidence map›Paper›PMID 38601084›Full record

ArticleUrology case reports2024

Hemophagocytic syndrome in A patient of upper urinary tract urothelial cancer after Bacillus Calmette-Guérin instillation: A case report.

Ting-Lien Li, Chi-Ping Huang, Chia-Yu Lin, Mao-Wang Ho, Chia-Hui Cho, Yung-Hsiang Chen, Wen-Chi Chen

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ting-Lien LiDepartment of Urology, China Medical University Hospital, Taichung, 404332, Taiwan.
Chi-Ping HuangDepartment of Urology, China Medical University Hospital, Taichung, 404332, Taiwan.
Chia-Yu LinDepartment of General Medicine, China Medical University Hospital, Taichung, 404332, Taiwan.
Mao-Wang HoDepartment of Infection, China Medical University Hospital, Taichung, 404332, Taiwan.
Chia-Hui ChoDepartment of Infection, China Medical University Hospital, Taichung, 404332, Taiwan.
Yung-Hsiang ChenDepartment of Urology, China Medical University Hospital, Taichung, 404332, Taiwan.
Wen-Chi ChenDepartment of Urology, China Medical University Hospital, Taichung, 404332, Taiwan.
China Medical University · TWAsia University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacillus Calmette-Guérin (BCG) therapy is an adjuvant treatment for urothelial carcinomas of the upper urinary tract (UTUC). BCG therapy can result in various side effects. We present a case of a 67-year-old female with a history of UTUC who developed disseminated tuberculosis following BCG instillation into the upper urinary tract after conservative management. This complex clinical scenario required a multidisciplinary approach, including antibiotic therapy, immunoglobulin infusion, and tailored tuberculosis treatment. The case underscores the importance of vigilance, early detection, and tailored interventions in managing disseminated tuberculosis arising from BCG therapy and rare complications like hemophagocytic syndrome.

Indexed as

Bacillus calmette-GuérinCase reportHemophagocytic syndromeUrothelial cell carcinoma

Identifiers

PMID38601084
PMCPMC11004083
OpenAlexW4393865612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.